Try our beta test site
1 study found for:    BI-1206
Show Display Options
Rank Status Study
1 Recruiting BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
Conditions: B-cell Lymphoma;   Chronic Lymphocytic Leukaemia;   Waldenström Macroglobulinaemia
Interventions: Biological: BI-1206 single agent dose escalation phase;   Biological: BI-1206 single agent expansion phase;   Biological: Combination of BI-1206 with Rituximab

Study has passed its completion date and status has not been verified in more than two years.